DALOTUZUMAB
UNII 6YI1L648RH

Substance Identification & Data

This profile provides standardized clinical and technical data for Dalotuzumab, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 6YI1L648RH.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 1005389-60-5 and the RxNorm Concept ID (RxCUI) 1432293. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

6YI1L648RH

CAS Registry Number

1005389-60-5

RxNorm Concept ID

1432293

Detailed Substance Profile

Preferred Name

DALOTUZUMAB

Official standardized name for this substance within the FDA UNII nomenclature system.

Molecular Formula

6YI1L648RH

The specific atomic composition represented as a molecular structure string.

NCI Thesaurus

C74011

National Cancer Institute reference terminology for clinical and research data.

PubChem CID

3035241

Unique identification number in the NCBI database of chemical substances.

INN ID

9200

Sequential identifier assigned via the WHO International Nonproprietary Name program.

USAN ID

UU-123

Identifier assigned by the United States Adopted Names Council.

Substance Type

protein

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Dalotuzumab. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.